Effective Data Sharing as a Conduit for Advancing Medical Product Development

[1] Bauchner H(2016)Data sharing: an ethical and scientific imperative JAMA 315 1238-1240

[2] Golub RM(2018)Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review Contemp Clin Trials Commun 7 156-164

[3] Fontanarosa PB(2020)Estimated research and development investment needed to bring a new medicine to market, 2009–2018 JAMA 323 844-853

[4] Fogel DB(2015)The project data sphere initiative: accelerating cancer research by sharing data Oncologist 20 464-e20

[5] Wouters OJ(2017)Assessment of a prognostic model, PSA metrics and toxicities in metastatic castrate resistant prostate cancer using data from Project Data Sphere (PDS) PLoS ONE 12 e0170544-8

[6] McKee M(2019)Prognostic value of baseline ALBI score among patients with colorectal liver metastases: a pooled analysis of two randomized trials Clin Colorectal Cancer 18 e61-606

[7] Luyten J(2018)The current status of drug discovery and development as originated in United States Academia: the influence of industrial and academic collaboration on drug discovery and development Clin Transl Sci 11 597-63

[8] Green AK(2019)The qualification of an enrichment biomarker for clinical trials targeting early stages of Parkinson’s disease J Park Dis 9 553-70

[9] Reeder-Hayes KE(2018)Dopamine transporter neuroimaging as an enrichment biomarker in early Parkinson’s disease clinical trials: a disease progression modeling analysis Clin Transl Sci 11 63-68

[10] Corty RW(2015)Improving clinical trial design for Duchenne muscular dystrophy BMC Neurol 15 153-455

[1] Bauchner H(2016)Data sharing: an ethical and scientific imperative JAMA 315 1238-1240

[2] Golub RM(2018)Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review Contemp Clin Trials Commun 7 156-164

[3] Fontanarosa PB(2020)Estimated research and development investment needed to bring a new medicine to market, 2009–2018 JAMA 323 844-853

[4] Fogel DB(2015)The project data sphere initiative: accelerating cancer research by sharing data Oncologist 20 464-e20

[5] Wouters OJ(2017)Assessment of a prognostic model, PSA metrics and toxicities in metastatic castrate resistant prostate cancer using data from Project Data Sphere (PDS) PLoS ONE 12 e0170544-8

[6] McKee M(2019)Prognostic value of baseline ALBI score among patients with colorectal liver metastases: a pooled analysis of two randomized trials Clin Colorectal Cancer 18 e61-606

[7] Luyten J(2018)The current status of drug discovery and development as originated in United States Academia: the influence of industrial and academic collaboration on drug discovery and development Clin Transl Sci 11 597-63

[8] Green AK(2019)The qualification of an enrichment biomarker for clinical trials targeting early stages of Parkinson’s disease J Park Dis 9 553-70

[9] Reeder-Hayes KE(2018)Dopamine transporter neuroimaging as an enrichment biomarker in early Parkinson’s disease clinical trials: a disease progression modeling analysis Clin Transl Sci 11 63-68

[10] Corty RW(2015)Improving clinical trial design for Duchenne muscular dystrophy BMC Neurol 15 153-455